Filter zurücksetzen
Stichworte
ОФТАЛЬМОЛОГИЯ ×
Zeige mehr Stichworte
Inhaltsverzeichnis
  1. 1. Klinisk studie
  2. 2. Rutindokumentation
  3. 3. Register- och kohortstudier
  4. 4. Kvalitetssäkring
  5. 5. Datastandard
  6. 6. Frågeformulär för patienter
  7. 7. Medicinsk specialitet
    1. 7.1. Anestesi
    1. 7.2. Dermatologi
    1. 7.3. HNO
    1. 7.4. Geriatrik
    1. 7.5. Gynekologi och obstetrik
    1. 7.6. Invärtes medicin
      1. Hematologi
      1. Infektionssjukdomar
      1. Kardiologi och angiologi
      1. Pneumologi
      1. Gastroenterologi
      1. Nefrologi
      1. Endokrinologi och ämnesomsättning
      1. Reumatologi
    1. 7.7. Neurologi
    1. 7.8. Oftalmologi
    1. 7.9. Palliativ medicin
    1. 7.10. Patologi och rättsmedicin
    1. 7.11. Pediatrik
    1. 7.12. Psykiatri och psykosomatik
    1. 7.13. Radiologi
    1. 7.14. Kirurgi
      1. Allmänkirurgi och bukkirurgi
      1. Neurokirurgi
      1. Plastikkirurgi
      1. Hjärt- och thoraxkirurgi
      1. Akutkirurgi och ortopedi
      1. Kärlkirurgi
    1. 7.15. Urologi
    1. 7.16. Odontologi samt mun-, käk och ansiktskirurgi
Ausgewählte Datenmodelle

Sie müssen eingeloggt sein, um mehrere Datenmodelle auszuwählen und diese herunterzuladen oder zu analysieren.

595 Suchergebnisse.
Relevanz Bewertung Neue zuerst Alte zuerst

Diabetic Eye Registry National Eye Database (NED) - SECTION 3: OCULAR FINDINGS AT PRESENTATION TO OPHTHALMOLOGY CLINIC

- 2021-09-20 - 3 Formulare, 2 Itemgruppen, 12 Datenelemente, 1 Sprache
Itemgruppen: Finding ocular Right Eye, Finding ocular Left eye
Diabetic Eye Registry. The National Eye Database (NED) is a service supported by the Ministry of Health (MOH) as an approach to collect health information. It collects data on incidences and distributions, and evaluates risk factors as well as treatment outcome of visually threatening eye diseases such as cataract, diabetic retinopathy, glaucoma and contact lens related corneal ulcer. National Eye Database, Clinical Research Centre, Kepong-Selayang Highway 68100, Batu Caves Selangor.http://www.acrm.org.my/ned/index.htm.

SECTION 2: OCULAR FINDINGS DURING REFERRAL

2 Itemgruppen 11 Datenelemente

SECTION 1: PATIENTS DEMOGRAPHY AND MEDICAL HISTORY

1 Itemgruppe 14 Datenelemente

MARS - Muenster Aging and Retina study Age-related macular degeneration - B. Eye diseases

- 2021-09-20 - 17 Formulare, 1 Itemgruppe, 83 Datenelemente, 1 Sprache
Itemgruppe: Eye disease
Age-related macular degeneration (AMD) is a retinal degenerative disease that occurs at an advanced age and is the major cause of central visual acuity loss and old-age blindness in its final stages. The aim of the MARS study is to identify factors that influence the progression and course of age-related macular degeneration in a prospective study. To date, the following studies have been carried out on the MARS cohort: MARS-I: 2001-2003; MARS-II: 2004 - 2007; MARS-III: 2007-2009; MARS +: 2010/11. The study is provided by Prof. Dr. Hense, Institute of Epidemiology and Social medicine, University Clinic of Muenster.

Administrative documentation

1 Itemgruppe 16 Datenelemente

A. Self-assessment of visual acuity

1 Itemgruppe 9 Datenelemente

Interview

1 Itemgruppe 5 Datenelemente

D. Slit lamp biomicroscopy I

1 Itemgruppe 18 Datenelemente

H.Quality of Life

1 Itemgruppe 24 Datenelemente

I. Family History

1 Itemgruppe 21 Datenelemente

Eligibility Non-arteritic Anterior Ischemic Optic Neuropathy NCT02019927

- 2021-06-22 - 1 Formular, 2 Itemgruppen, 14 Datenelemente, 1 Sprache
Itemgruppen: Inclusion Criteria, Exclusion Criteria
Electric Stimulation of the Eye to Improve Vision After Trauma; ODM derived from: https://clinicaltrials.gov/show/NCT02019927

Age Related Macular Degeneration Registry National Eye Database (NED) - Age Related Macular Degeneration Registry

- 2021-09-20 - 1 Formular, 9 Itemgruppen, 86 Datenelemente, 1 Sprache
Itemgruppen: Administrative Data, Demography, Risk Factors, Quality of Life, Medical History, Clinical features, Investigation, Diagnosis, Therapy
Age Related Macular Degeneration Registry. The National Eye Database (NED) is a service supported by the Ministry of Health (MOH) as an approach to collect health information. It collects data on incidences and distributions, and evaluates risk factors as well as treatment outcome of visually threatening eye diseases such as cataract, diabetic retinopathy, glaucoma and contact lens related corneal ulcer. National Eye Database, Clinical Research Centre, Kepong-Selayang Highway 68100, Batu Caves Selangor. http://www.acrm.org.my/ned/index.htm.

Swedish National Quality Registry for Cataracts (NCR Nationella Kataraktregistret) - Formulär 1: Basregistret för 2018 års kataraktoperationer (Base register for 2018 cataract surgeries)

- 2019-01-16 - 1 Formular, 16 Itemgruppen, 43 Datenelemente, 2 Sprachen
Itemgruppen: Hospital Number, Person Number, Eye to be operated, Preoperative visual acuity, NIKE Indication group, Waiting list entry, Date of surgery, Ocular Comorbidities in eye to be operated, Type of Surgery, Material of Lens, Special Properties of lens, peroperative difficulties, intracameral Antibiotics, Peroperative damage posterior capsule or zonule, Postoperative prophylaxis of inflammation, Surgeon's signature
Swedish National Quality Registry for Cataracts (NCR Nationella Kataraktregistret) Head of Registry: Anders Behndig, Professor, Norrland University Hospital, Umeå, Sweden. Adress of Registry: Nationella Kataraktregistret Landstinget Blekinge 371 81 KARLSKRONA Sweden Source: http://rcsyd.se/kataraktreg/registrering/formular-nationella-kataraktregistret This ODM-File is derived from "Formulär 1: Basregistret för 2018 års kataraktoperationer" (Base register for cataract surgeries of the year 2018). To be filled separately for each eye (even if bilateral surgery on the same day). English translation not validated.

LASER ADMINISTRATION FELLOW EYE (UNSCHEDULED) CRFs Roche FVF4170G Macular Edema NCT00473382

- 2017-06-28 - 1 Formular, 2 Itemgruppen, 10 Datenelemente, 1 Sprache
Itemgruppen: Patient administration, LASER ADMINISTRATION STUDY EYE
Terms of use: You may not use this document or the information contained herein to a regulatory authority in connection with an application for a marketing authorization or any other regulatory submission without the express written consent of Roche Study #: FVF4168g Drug: Ranibizumab Study Title: A Phase III, Double-Masked, Multicenter, Randomized, Sham-Controlled Study Of The Efficacy And Safety Of Ranibizumab Injection In Subjects With Clinically Significant Macular Edema With Center Involvement Secondary To Diabetes Mellitus

Study Eye Selection Screening Ranibizumab Macular Edema Secondary To Branch Retinal Vein Occlusion FVF4165g - Study Eye Selection Screening

- 2018-03-18 - 1 Formular, 1 Itemgruppe, 7 Datenelemente, 1 Sprache
Itemgruppe: study eye
Study part: Study Eye Selection Screening. A Phase III, Multicenter, Randomized, Sham Injection-Controlled Study Of The Efficacy And Safety Of Ranibizumab Injection Compared With Sham In Subjects with Macular Edema Secondary To Branch Retinal Vein Occlusion.

Study Eye Selection Screening Ranibizumab Macular Edema Diabetes Mellitus FVF4168g - Study Eye Selection Screening

- 2018-03-20 - 1 Formular, 1 Itemgruppe, 6 Datenelemente, 1 Sprache
Itemgruppe: study eye
Study part: Study Eye Selection Screening. A Phase III, Double-Masked, Multicenter, Randomized, Sham-Controlled Study Of The Efficacy And Safety Of Ranibizumab Injection In Subjects With Clinically Significant Macular Edema With Center Involvement Secondary To Diabetes Mellitus.

Swedish National Quality Registry for Cataracts (NCR Nationella Kataraktregistret) - Formulär 2B: 2018 års kataraktregistrering - Uppföljningsformulär (Follow-up Form for registering of cataracs in 2018, Part B)

- 2018-07-09 - 2 Formulare, 6 Itemgruppen, 23 Datenelemente, 2 Sprachen
Itemgruppen: Follow-up status, Final control, Visual Acuity right eye, Visual Acuity left eye, Conditions of operated eye, Responsible Physician for final follow-up
Swedish National Quality Registry for Cataracts (NCR Nationella Kataraktregistret) Head of Registry: Anders Behndig, Professor, Norrland University Hospital, Umeå, Sweden. Adress of Registry: Nationella Kataraktregistret Landstinget Blekinge 371 81 KARLSKRONA Sweden Source: http://rcsyd.se/kataraktreg/registrering/formular-nationella-kataraktregistret This ODM-File is derived from "Formulär 2A/B: 2018 års kataraktregistrering - Uppföljningsformulär" (Follow-up Form for registering of cataracs in 2018). Part A to be filled after surgery, Part B to be filled when medical checks after the current cataract surgery are not longer needed and glasses can be prescribed, but not later than 3 months after surgery. In practice, the end date is between 6 weeks and 3 months after surgery depending on type of cataract surgery and postoperative course. Attention: All varibales are mandatory. English translation not validated.

Formulär 2A: 2018 års kataraktregistrering - Uppföljningsformulär (Follow-up Form for registering of cataracs in 2018, Part A)

8 Itemgruppen 17 Datenelemente

Study Eye Selection Screening Ranibizumab Macular Edema Diabetes Mellitus FVF4170g - Study Eye Selection Screening

- 2018-03-21 - 1 Formular, 1 Itemgruppe, 6 Datenelemente, 1 Sprache
Itemgruppe: study eye
Study part: Study Eye Selection Screening. A Phase III, Double-Masked, Multicenter, Randomized, Sham-Controlled Study Of The Efficacy And Safety Of Ranibizumab Injection In Subjects With Clinically Significant Macular Edema With Center Involvement Secondary To Diabetes Mellitus.

STUDY EYE SELECTION (SCREENING) CRFs Roche FVF4168G Macular Edema NCT00473330

- 2017-06-08 - 1 Formular, 2 Itemgruppen, 6 Datenelemente, 1 Sprache
Itemgruppen: Patient administration, Eligibility Criteria
Terms of use: You may not use this document or the information contained herein to a regulatory authority in connection with an application for a marketing authorization or any other regulatory submission without the express written consent of Roche Study #: FVF4168g Drug: Ranibizumab Study Title: A Phase III, Double-Masked, Multicenter, Randomized, Sham-Controlled Study Of The Efficacy And Safety Of Ranibizumab Injection In Subjects With Clinically Significant Macular Edema With Center Involvement Secondary To Diabetes Mellitus

Vision Testing (Eye) Pazopanib Macular Degeneration MD1103367 - Vision Testing (Eye)

- 2018-06-10 - 1 Formular, 6 Itemgruppen, 22 Datenelemente, 1 Sprache
Itemgruppen: Subjective Refraction Right Eye, Subjective Refraction Left Eye, Visual Acuity, lntraocular Pressure, Slip Lamp Examination, Fundus Examination
Study part: Vision Testing (Eye). A phase 1 single-masked, randomized (with respect to placebo), placebo-controlled, parallel-group, dose-rising study to evaluate the safety, tolerability and pharmacokinetics of repeat oral doses of GW786034 in elderly healthy volunteers. Trade Name: Votrient. Clinical Study ID: MD1103367.

Kontakt

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video